Post your pick HERE (6th Edition)

[hermanpu]

KONG    Kongzhong Corp (NASDAQ GM)

Kongzhong is going to lead the pack in entertainment for mobile phones in China (I hope) and has suffered from the poor US market but makes its money in China so the PPS has depreciated unlawfully. The stock I believe has bottomed out or is close to it, even though it is not the best entry point, the contest starts tommarro and the potential gains outweigh the poor entry point.
Heres a description copy and pasted off yahoo finance.

KongZhong Corporation, together with its subsidiaries, provides wireless interactive entertainment, media, and community services to mobile phone users in the People's Republic of China. It also engages in the development, distribution, and marketing of consumer wireless value added services. The company offers its services through 2.5G technology platforms, including WAP, MMS, and Java that offers graphics, content, and interactivity wireless services. In addition, it provides various data and voice services through 2G technology platforms, such as SMS, IVR, and CRBT. The company's interactive entertainment services include mobile games, pictures, karaoke, electronic books, and mobile phone personalization features, such as ringtones, wallpapers, clocks, and calendars. Its media services provide content, such as domestic and international news, entertainment, sports, fashion, lifestyle, and other special interest areas. The community services comprise interactive chat, message boards, dating, and networking. Further, the company develops wireless Internet portal, www.cota.cn, through customers can visit form their mobile phones by using WAP browser while accessing China's 2.5G mobile networks. It sells and markets its services to mobile phone users, telecommunications operators, key industry players, and owners of brand names through Web site, promotional events, direct marketing, and media advertising. KongZhong was founded by Yunfan Zhou and Nick Yang as Communication Over The Air, Inc. in 2002 and changed its name to KongZhong Corporation in 2004. The company is headquartered in Beijing, China.

[pnguyen652004]

My pick: ZL - Company name: Zarlink Semiconductor

Reason:
If I have some money, I will put more in it.  Right now, its price is still below my buying point. 
Don't know much about reading chart and it's hard to analyze it for me.

Chart:  I don't know how to post chart.  If anyone can help to post it, thank you.

If this post is not qualified, just delete it.

************************
NOT VALID (Post count < 10)
************************

[ScottishTrader]

Right then, another stock picking contest, lets hope we (almost) all do better than the last one!!

So, my pick is gonna be Insmed (INSM).

Has had a lot of coverage here in the last several months, with a lot of expectations riding on the commercialization of their growth hormone drug Iplex, which is also seen to have significant potential in other areas, most notably diabetes.  However, on release, the share price didn't exactly go through the roof (though it did get a decent little rally a couple of weeks ago when it broke out of the falling wedge). 

It appears that this is primarily due to uncertainties surrounding patent issues in a legal suit with a competitor Tercica.  This week INSM's share price tanked on news that the California court ruled against Insmed on Tercica's patent infringement case, however, I think this is overdone.  Essentially, this court's decision means that the patent dispute will have to be resloved at trial in November, as opposed to being thrown out now, which was what Insmed was asking for and what the court ruled against.  In any case this legal action is not going to stop Insmed producing, marketing and selling IPlex, which appears to have several distinct safety and efficacy advantages over Tercica's drug. 

In the mean time, with IPlex's release to market a few weeks earlier than expected this quarter should hopefully boost both earnings and patient numbers for their first quarter of sales.  Q2 Earnings should be announced end of July/beginning of August, within the time-frame of the contest.  If IPlex uptake exceeds expectations, I think that the share price should jump.

Technically, as I mentioned, INSM recently broke out of a 6 month descending wedge after the run-up following FDA IPlex Certification.  This weeks tank brought it back down to the descending support line and to its pre-approval levels, representing a good value entry.  Right here, I think the risk/reward looks appealing.  From Friday's close at 1.29, the first resistance would be the bottom of the gap, at 1.45, representing a 12.5% gain.  Second target is 1.65 resistance, a 28% gain from here, and finally, a 3rd target of the recent gap to crap sell-off at 1.83, which would be a 42% gain.

I still don't think this would represent fair value, but I do think all of these are achievable in the next month, so I'm gonna pick it (I already picked some up last week too )

[healey]

My pick this time is     PRZ      
PainCare Holdings, Inc.,
Through its subsidiaries, provides healthcare services for the treatment of pain through physician practices and surgery centers in North America. The company operates 21 pain-focused physician practices and 9 outpatient surgery centers through its physicians trained in interventional pain management, orthopedics or physiatry using medical technologies, clinical practices, and equipment. PainCare also provides intraoperative monitoring and interpretation services to hospitals and surgeons. In addition, it offers medical real estate and development services. PainCare, formerly Hi-Profile Corporation, was founded in 1984 and is headquartered in Orlando, Florida.

This is one I have been watching and trying to buy on a pull back...I stepped in at 1.75 last week of June and was happy to see it break and hold the ascending triangle. Also holding at the 1.70 support was important. It was moving a few days prior to earnings release on June 21 and jumped with the announced numbers

-- Pain Care Holdings Inc. 06/21/2006. The Orlando, Fla. medical services provider reported earnings of $11.9 million, or 17 cents a share. In the same quarter last year it posted a loss of $27.8 million, or 63 cents a share. Excluding items, the company said its earnings were 5 cents a share vs. 4 cents a share last year. The company posted revenues of $23.3 million, up 64% from $14.2 last year.

The price rose on this news also on July 6

PainCare Holdings Regains Compliance With AMEX Continued Listing Standards
PR Newswire (Thu, Jul 6)

I see clear skies til the 2.90 gap then there will be a stall, I hope at that point I will have a chance to get out at the open. Only 30-35 % but the way I have performed in previous contests....I will take it, and of course my personal portfolio will thank me. I neeed alittle positive after the last couple of months.
Good Luck All
Cheers

[setravis]

Let's throw this one out there.....

1. BDCO   Blue Dolphin Energy Co.

2. Sector Snap: Oil and Gas Soar
   Impressive volume during the spring price rise.
   Strong hands watched it fall to lower levels without selling.

Business Overview;
BRIEF: For the three months ended 31 March 2006, Blue Dolphin Energy Compnay's revenues totaled $1.1M, up from $359K. Net income totaled $137K, vs. a loss of $730K. Revenues reflect increased revenue from Oil & gas exploration & production segment. Net income also reflects lower depletion, depreciation and amortization expenses, decreased general & administrative expense and lower interest & other expenses. http://www.blue-dolphin.com/

Float (mil) 6.20....Shares Outstanding (mil) 11.55

Price Performance Actual (%)  Vs. S&P 500 (%)
4 Week         35.38                       33.97
13 Week       11.99                       14.65
26 Week       155.09                     159.11
52 Week       88.70                       80.71
Year To Date 155.09                     151.62


Profile:
 
Blue Dolphin Energy Co.
801 Travis
Suite 2100
Houston, TX 77002
United States - Map
Phone: 713-227-7660
Fax: 713-227-7626
Web Site: http://www.blue-dolphin.com

DETAILS  
Index Membership: N/A
Sector: Basic Materials
Industry: Independent Oil & Gas
Full Time Employees: 7


BUSINESS SUMMARY  
Blue Dolphin Energy Company, through its subsidiaries, engages in the exploration, acquisition, development, and operation of oil and gas properties, as well as in the provision of pipeline transportation and related services for producer/shippers in the United States. It primarily focuses its oil and gas activities in the western Gulf of Mexico, off the coast of Texas. The company owns interests in High Island Block 37, which is located 15 miles south of Sabine Pass, offshore Texas that covers approximately 5,760 acres; High Island Block A-7 that is located 33 miles southeast of Boliver Peninsula, offshore Texas and covers approximately 5,760 acres. It also owns interest in West Cameron Area Block 212 prospect. As of December 31, 2005, the company had net proved and developed reserves of approximately 0.9 thousand barrels of oil; and net proved and developed reserves of approximately 341 million cubic feet of gas. Blue Dolphin Energy's pipeline transportation and related services include the operation of the Blue Dolphin Pipeline comprising the offshore segment that transports gas and liquids consisting of approximately 34 miles of 20-inch pipeline from a platform in Galveston Area Block 288 to shore; and the onshore segment consisting of approximately 2 miles of 16-inch pipeline for transportation of gas from the shore facility to a sales point at a Freeport, Texas chemical plants' complex and intrastate pipeline system tie-in. Its pipeline systems also comprise The Buccaneer Pipeline, an 8-inch liquids pipeline, transports crude oil and condensate from the storage tanks to our barge-loading terminal on the Intracoastal Waterway near Freeport, Texas for sale to third parties; and Galveston Area Block 350 Pipeline, consisting of 8-inch, 12.78 mile pipeline extending from Galveston Area Block 350 to an interconnect with a transmission pipeline in Galveston Area Block 391. The company was founded in 1986 and is based in Houston, Texas.


Technicals
Percentage Gainer

Last Price Quote is:
16.10%above 13-day EMA
23.41%above 50-day EMA
RS Rating: 98  

Fundamentals
Key Data:
Market Cap (M): $63.63  
P/E Ratio: 39.06  
PEG Ratio: N/A  
Next Earnings: N/A
Last Analyst Rating: N/A

Support @ $5.47...5.08...4.39
Resistance @ $5.75...6.17...8.00
MACD is Bullish

Volume: 2,194,398
Avg Vol (3m): 1,598,700

[dwest718]

This month... I make my pick on the "Can't fall any further..." theorem.  I've made picks out of my portfolio every contest until now... and I won't stop on this one  .

I pick CYTO.  Looks like it might be bottoming  .  RSI is very, very low and MACD seems to have bottomed and appears to be recovering.  This thing has dropped like a rock since the CFO resigned but looks somewhat technically attractive.  Has a good 30% in it once it gets on a bit of a better track.  If the contest lasted a week, I wouldn't choose this stock... but a month should give it enough time to make a turn around if it does.  Otherwise I will consider getting out of my actual position.  There are no fundamental reasons to buy this stock... just modest technicals and a month to waste 

Here's the chart:

[Ramsburg]

1) My pick: EPIX Pharmaceuticals Inc. (EPIX)

2) Reasons:
This is a technical play, I've already a setup running on our Premium Portfolio, and now I want to test it here at the contest
EPIX just triggered an Inverted Head & Shoulders pattern, the breakout of the neckline was made last Wednesday, already with a throwback to that level during Friday with a good reaction to the upside and volume above average. Another catalyst for this trade is the big short interest on the stock and the potential short squeeze on perspective.
The target of this technical pattern is $6.13, with the right market conditions I think EPIX could get there during the contest.

3) Chart:

[akclide]

My pick STEM
Showed up on my radar.
Volume on friday up 126%.
This is going to be very big in future.I am betting on being a little better in very near future.
A part of an article that really speaks volume

Dr. Douglas Kerr, assistant professor of neurology at Johns Hopkins Hospital in Baltimore, used experimental stem cell technology to successfully repair lab rats' damaged spines, restoring mobility to their legs.If scientists are able to repeat this success in humans, stem cells could eventually be used to help paralyzed patients walk again, even in cases where spinal cords are severed by motorcycle accidents, sports injuries or war wounds. Kerr's experiment gives hope to a broad range of therapies for the rebuilding of kneecaps, brain cells, and even the pancreas in diabetics. Stem cells are being considered as treatments for multiple sclerosis and brain damage, and diseases like Lou Gehrig's, Alzheimer's and Parkinson's


There has been some renewed interest generated after the above article.The industry has been strugling lately.I think these stocks are going to be coming back into rotation soon.Hopefuly before the contest is over.
Technicaly speaking : It is showin uptrend in price since around middle of june . strength in volume 3 month ave.1274450 friday vol. 2655565.

Breaking out of a downward chanel.
touching a short term ascending triangle

[eliteG]

1) My pick: Travelzoo Inc. (TZOO)

2) Reasons:
This is an earnings trend technical play.  TZOO has earnings Thursday July 20th.  The stock is one of the most volatile out there.. and it is seeing even more action than usual lately.  Volume is high.  I consider this a very risky play but potential on this one is for a run into earnings or perhaps some kind of earnings surprise.  Insiders sold heavily on the last run-up but price has maintained nicely above all major moving averages.  It is travel season.. more people online then ever.. lets see if they used Travelzoo. 

3) Charts:

[fous]

Pick: PLB

Company Profile
American Italian Pasta Company is primarily a producer and marketer of dry pasta in North America. Its product line, which consists of over 3,500 items or stock-keeping units (SKUs), includes long goods, such as spaghetti, linguine, fettuccine, angel hair and lasagna, and short goods such as elbow macaroni, mostaccioli, rigatoni, rotini, ziti and egg noodles. In many instances, the Company produces pasta according to customers' specifications. It makes over 220 different shapes and sizes of pasta products in over 225 package configurations, including bulk packages for institutional customers and smaller individually wrapped packages for retail consumers. The Company contracts with third parties for the production of certain specialized pasta shapes, such as stuffing shells and manicotti, which are necessary to offer customers a range of pasta products. Purchased pasta represented less than 1% of its total unit volume during the fiscal year ended October 1, 2004 (fiscal 2004).

PLB has been in a huge downtrend for the past 5 years dropping from $50 to below $5. But the chart has been looking better and better the last couple months making huge gains and forming a nice looking top heavy symmetrical triangle. On top of that insiders have been buying as recently in the low 8's which is definatley a bullish sign.

Good luck fellow contestants!

-fous

[Tirebldr]

CH Robinson Worldwide ( a NASDAQ stock) is a fairly expensive stock compared to the other picks I have observed thus far, but I think CHRW has just a good a chance to move assuming the market will co-operate. She is my pick folks.

CH Robinson provides freight transportation services and logistics solutions to companies in North and South America, Europe and Asia. CHRW is the largest freight brokerage firm in the United States.

Being this is my first contest to enter, I'm finding it a challenge to enter pertinent information in a timely manner. Mostly because, as a learner, I really do not have it all firm in my head yet, but know of the importance. Now that is humbling to admit.   But here goes:

I use IBD quite a lot these days to evaluate my watchlist, so per IBD the Ratings as of 7/09/2006 are as  follors:

EPS = 93
RS = 93

Transportation-Services Group given A+ rating
CHRW is rated #2 within that group and has an overall rating of 99
Rates in the top 40% of all publicly traded companies based on 4 fundamental factors: Sales growth rate over the last 3 quarters, before  and after tax profit margins, and return on equity (ROE) (given B rating)

Beta 1.5
IBD gives CHRW a Relative Strength rating of 93 of which I expect to turn up soon as she once again finds strong MM support sometime this next week.

Average Daily Volume is 1,235,100
5.9% from its 52 week high
Market Capitalization of $9016 Million

A weekly chart shows CHRW on a steady and consistent incline since 1998. In the middle of April of this year, along with many other strong stocks, she took a slight downward consolidation, finding support before its 200d ema on the 13th of June and has been moving upwards since that time, finding consistent MM support at the 10ma. Last Friday saw a small bounce just above the 10d once again. We may see one more day of profits before turning skyward once again.

TSV (Middle section) is a Telechart only indicator. Looking at the TSV you can see how it accurately shows the movement of the stock. Notice on 6/13 when CHRW found strong MM support the TSV began working its way above its 19d avg. and is now continuing up above its zero center line far away from its daily average.

[Lucas Scott]

My pick is GV

Well known here as one of the best picks in 3SoF history and simultaneously as one of the worst trades in 3SoF history. GV drove one member to a psychotic break: http://www.3stocksonfire.org/trading/index.php?topic=5301.msg63185#msg63185

I like the cup and handle as displayed on the chart below. I also like that I should be able to get an entry price near the 20 ema. The pullback from the $2.80 high was steep and exacerbated IMO by 1. the overall market weakness, 2. possibly the shenanigans at HOM, another hurricane play (guilt by association, though GV and HOM are in different areas of hurricane relief), and 3. sellers who helped run up the price thinking GV was a gold play, and then helped run it back down.

Goldfield is a leading provider of electrical construction and maintenance services in the energy infrastructure industry in the southeastern United States. The company specializes in installing and maintaining electrical transmission lines for a wide range of electric utilities. Goldfield is also involved in the development of high-end condominium projects on Florida's east coast.

Revenue increased 70% in Q1 06 from Q1 05. Current PE is ~13.

[masternic35]

Hi All,

My Pick is an old timer: EZM

This is a pure Technical play. We're reaching a point of resistance so it's quite risky. I think it's a double or nothing play.

--> For those who don't know EZM :
EuroZinc Mining Corporation engages in the acquisition, exploration, development, and mining of base metal deposits internationally. The company owns the Neves-Corvo copper mine; and the Aljustrel zinc, lead, and silver project in southern Portugal. EuroZinc was founded in 1981 and is headquartered in Vancouver, Canada.

[QuestSolver]

CLBE - CalbaTech

these links should show everyone investing in CLBE just exactly what they are about and why they are going to increase in value tremendously.For those here who remember our pick of BIPH from .09 to .20's as a strong buy and it ran to $3.60 within a few months and TDCP from the subs to $3's within the same year CLBE is projected to reach $2 to $4 range in the not so distant future.DD it closely and my personal contact with Paul in IR says a PR is due out any time now on the opening of the new MicroBank for stem cell collections.CLBE is an adult stem cell med sector company and there is no unethical restrictions.

http://www.calbatech.com/

http://www.kdmedical.com/

http://www.molecula.com/

http://www.molecula.com/new/index2.html

http://www.solanamedspas.com/home_B.htm

http://www.biotechnologyireland.com/...Q=BF_COMP_9172

Adult, not embryonic, stem cells better for research

http://www.statenews.com/op_article.phtml?pk=36817


http://english.chosun.com/w21data/ht...510060016.html

Catholic Church Funds Adult Stem Cell Research

first link is a couple years old but gives crystal clear direction for now.

http://www.21stcenturysciencetech.co...stem_cell.html

BIOLOGY & MEDICINE

The Case for Adult Stem Cell Research


*********** Msg from Ramsburg ***************
Please read the rules, this pick is not valid
******************************************

[1reilly]

NVAX
Once again I'm going to try this one. There are a number of reasons for this choice, I'll only list a few:
A. The company had given every indication that trial results would be completed by the end of June. I expect some published results during the contest period.
B. They just hired a new IR Vp. I expect this new VP to start earning her keep and believe we will start to see a reshaping of how this company wants the street to view their business plan.
C. The stock has just experienced a short term decline on low volume over the last few trading days back down to previous good entry levels.
D. The company has an earnings report and a business conference scheduled by AUG 15th. My bet is stock moves up in anticipation of these events.
E. finally  this stock no longer seems to have the momo crowd interested and retail has I believe given up on this one. Contrary opinion tells me I might like this.

Good luck to all